Sort
82,697 grants matching “vaccine development”
Type-I Interferons drive cell-autonomous immunity to malaria
$755,000Sam Kurup · University Of Georgia · R01 · FY2025 · AI
Characterizing the therapeutic efficacy of CD8 T cell responses induced by the IL-15 superagonist ALT-803
$754,981Shelby L Oconnor · University Of Wisconsin-Madison · R01 · FY2023 · AI
Defending Against Systemic Mycoses
$754,932George S. Deepe · University Of Cincinnati · P01 · FY2006 · AI
ANTIBODY EFFECTOR FUNCTION IN PROTECTION AGAINST HIV-1
$754,925Scripps Research Institute · R01 · FY2004 · AI
Optimizing Adjuvants and Needle Free Delivery Methods for Oral HIV Vaccination
$754,852Rama Rao Amara · Emory University · R01 · FY2018 · DE
Defending Against Systemic Mycoses
$754,826George S. Deepe · University Of Cincinnati · P01 · FY2007 · AI
Prevention and Treatment of Pneumocystis Pneumonia
$754,801Karen A Norris · University Of Georgia · R01 · FY2023 · AI
Prevention and Treatment of Pneumocystis Pneumonia
$754,801Karen A Norris · University Of Georgia · R01 · FY2024 · AI
Reactions And Immunochemistry Of Carbohydrates
$754,795Pavol Kovac · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2014 · DK
Papillomavirus Virion Proteins and Vaccines
$754,757John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA
Papillomavirus Virion Proteins and Vaccines
$754,666Douglas R. Lowy · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
Accelerating malaria prevention through enhanced analysis of transmission and RTS,S vaccination in Malawi
$754,657Don P Mathanga · Kamuzu University Of Health Sciences · U19 · FY2025 · AI
PREVALENCE AND DETERMINANTS OF ORAL HPV INFECTION IN THE US POPULATION
$754,633Maura L Gillison · Ohio State University · R01 · FY2012 · DE
Temporal Transcriptomics in Hospitalized COVID-19 Patients from Disparately Impacted Ancestral Groups for Therapeutic Discovery
$754,597Douglas Jay Perkins · University Of New Mexico Health Scis Ctr · R01 · FY2022 · AI
Development of therapeutic chemokine-based formulations
$754,563Arya Biragyn · National Institute On Aging · ZIA · FY2014 · AG
Understanding the mechanisms of antibody-mediated transcytosis of ZIKV within the placenta
$754,544Mehul Shamal Suthar · Emory University · R01 · FY2023 · AI
Core B_Silvestri
$754,534Guido Silvestri · Scripps Research Institute, The · P01 · FY2021 · AI
Protection and Immunity after Polyanhydride Nanoparticle Vaccination against Avian Influenza A Virus
$754,519Kevin L Legge · University Of Iowa · R01 · FY2025 · AI
Mechanisms of MERS-CoV Entry, Cross-species Transmission and Pathogenesis
$754,420Ralph S Baric · Univ Of North Carolina Chapel Hill · R01 · FY2015 · AI
Preclinical Studies and Mucosal Responses
$754,406Rama Rao Amara · Geovax, Inc. · U19 · FY2007 · AI
Vascular macrophages and T cells in atherosclerosis
$754,375Klaus F. Ley · Augusta University · R35 · FY2024 · HL
NIH Director's Pioneer Award (RMI)
$754,346Joseph M McCune · University Of California, San Francisco · DP1 · FY2008 · OD
NIH Director's Pioneer Award
$754,346Nathan D Wolfe · University Of California Los Angeles · DP1 · FY2007 · OD
Vaccines and Therapeutics for Anthrax
$754,329Stephen Leppla · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Targeting tonsillar B cells for the induction of effective mucosal immunity to HIV
$754,311James J Kobie · University Of Rochester · R01 · FY2018 · DE